Search

everythinglearnresearchcommunity

for

Search:↓

The scaffold is a promising material for wound healing and tissue engineering.

Peptide hydrogels are promising for drug delivery and tissue repair in medicine.

β-catenin, Shh, and Bmp signaling control hair follicle development.

MCSP may help identify and regulate skin stem cells, affecting hair growth and regeneration.

Immune cells in Hidradenitis suppurativa become more inflammatory and may be important for treatment targets.

Hydrogels can enhance stem cell activity, but more research is needed to optimize their use.

Biomimetic scaffolds are better than traditional methods for growing cells and could help regenerate various tissues.

Nanotechnology can improve tissue healing by controlling immune responses.

Peptide-based hydrogels are promising for healing chronic wounds effectively.

A surface with VEGF can specifically capture endothelial cells from flowing fluids.

New treatments for COVID-19 show promise, but more effective antiviral drugs are needed.

Mutant keratins cause inflammation in Epidermolysis Bullosa Simplex, suggesting targeting them could help treat the disorder.

New treatments like nanotechnology show promise in improving skin cancer therapy.

Adenosine receptors could be promising targets for treating inflammatory skin diseases like psoriasis.

CD34 is a marker for isolating stem-like cells in mouse hair follicles.

Sox2-positive cells determine specific hair follicle types in mammals.

Disruptions in mammary stem cell division can lead to cancer, but targeting these processes might help treat breast cancer.

Protein ubiquitylation is crucial for controlling stem cell functions and could be targeted for cancer treatment.

3D bioprinting in plastic surgery could lead to personalized grafts and fewer complications.

Soluble CD83 speeds up wound healing and reduces scarring.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

ERULUS controls root hair growth by regulating cell wall composition and pectin activity.

Advanced imaging methods have improved understanding of cancer cell interactions and treatment strategies.

Current treatments for Alopecia Areata have mixed success, and there's a need for better, more accessible options and support for affected individuals.

New-onset fibromyalgia after COVID-19 is poorly understood and needs more research.

Treg cell-based therapies might help treat hair loss from alopecia areata, but more research is needed to confirm safety and effectiveness.

A mycobacterial protein shares a similar region with a human skin protein, possibly affecting skin diseases.

A woman with a rare autoimmune disorder had a blister on her eye and unique immune reaction, which was effectively treated with medication.

TH antibodies in vitiligo and AA patients recognize the same protein parts.

Melanogenesis-related proteins may trigger immune responses in alopecia areata patients.